Drug Channels Archive for July, 2020

Click a link below to view the mailing archive as if it had been sent to you.

2020-07-29 07:39Drug Channels News Roundup, July 2020: Diabetes Costs, Regeneron's Copay Support, MA Rethinks Coupons, My Favorite Chart Updated, and ABC's Steve Collis
2020-07-26 20:15Trump's Executive Orders on Drug Pricing: The Drug Channels Guide to Industry Implications
2020-07-24 07:39Drug Channels - Clarity in the Face of COVID-19: Building an Effective Patient Savings Strategy
2020-07-23 07:46Drug Channels - How Hospitals and PBMs Profit—and Patients Lose—From 340B Contract Pharmacies
2020-07-21 07:41Drug Channels - PBM-Owned Specialty Pharmacies Expand Their Role In—and Profits From—the 340B Program
2020-07-14 07:19Drug Channels - Walgreens and CVS Top the 28,000 Pharmacies Profiting from the 340B Program. Will the Unregulated Party End?
2020-07-10 07:34Drug Channels - CMS Best Price Proposal and Copay Assistance: How New Rule Could Change the Access Landscape
2020-07-09 09:17Drug Channels - The Top 15 Specialty Pharmacies of 2019: PBMs Stay On Top (rerun)
2020-07-08 08:42Drug Channels - Four Unexpected Ways that the COVID-19 Medicaid Boom Will Affect PBM and Pharmacy Profits (rerun)
2020-07-07 07:45Drug Channels - Pharmacy DIR Fees Hit a Record $9 Billion in 2019—That's 18% of Total Medicare Part D Rebates (rerun)
2020-07-06 07:48Drug Channels - The Top 15 U.S. Pharmacies of 2019: Specialty Drugs Drive the Industry's Evolution (rerun)


<< Archive IndexSubscribe >>